Capecitabine Accord

Capecitabine Accord is an oral medication used in cancer treatment. It belongs to a class of drugs known as antimetabolites, which interfere with the growth of cancer cells. This medication is manufactured by Accord Healthcare S.L.U. and is intended for oral use.

Capecitabine is primarily used in the treatment of certain types of cancer, including breast cancer and colorectal cancer. It works by slowing or stopping the growth of cancer cells in the body. The medication is often prescribed as part of a combination therapy, depending on the specific type and stage of cancer. Patients should consult their healthcare provider to understand the appropriate use of capecitabine for their condition.

Common effects of capecitabine may include nausea, vomiting, diarrhea, and fatigue. Some patients may also experience hand-foot syndrome, which is characterized by redness, swelling, and pain in the palms of the hands and soles of the feet. These effects can vary in severity and may require medical attention if they become severe or persistent.

Capecitabine should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their doctor.

Capecitabine may interact with other medications, including certain antacids, blood thinners, and other cancer treatments. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while taking capecitabine, as it may increase the risk of side effects.